切换至 "中华医学电子期刊资源库"

中华胸部外科电子杂志 ›› 2016, Vol. 03 ›› Issue (03) : 164 -169. doi: 10.3877/cma.j.issn.2095-8773.2016.03.08

所属专题: 文献

论著

鲁西冀南地区低剂量螺旋CT在肺癌筛查中的应用
解耀锃1,(), 霍晓恺2, 鲁强1, 李吉臣1   
  1. 1. 252600 山东临清,聊城市第二人民医院CT室
    2. 252600 山东临清,聊城市第二人民医院超声科
  • 收稿日期:2016-05-20 出版日期:2016-08-28
  • 通信作者: 解耀锃

Clinical application of low-dose spiral CT screening for lung cancer in western Shandong and southern Hebei

Yaozeng Xie1,(), Xiaokai Huo2, Qiang Lu1, Jichen Li1   

  1. 1. Department of CT, the Second People’s Hospital of Liaocheng, Linqing 252600, China
    2. Department of Ultrasound, the Second People’s Hospital of Liaocheng, Linqing 252600, China
  • Received:2016-05-20 Published:2016-08-28
  • Corresponding author: Yaozeng Xie
  • About author:
    Corresponding author: Xie Yaozeng, Email:
引用本文:

解耀锃, 霍晓恺, 鲁强, 李吉臣. 鲁西冀南地区低剂量螺旋CT在肺癌筛查中的应用[J/OL]. 中华胸部外科电子杂志, 2016, 03(03): 164-169.

Yaozeng Xie, Xiaokai Huo, Qiang Lu, Jichen Li. Clinical application of low-dose spiral CT screening for lung cancer in western Shandong and southern Hebei[J/OL]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2016, 03(03): 164-169.

目的

探讨鲁西冀南地区低剂量螺旋CT(LDCT)在不同性别和年龄人群中肺癌检出率的差异,为制定更适宜的筛查方案提供依据。

方法

回顾性分析2015年在聊城市第二人民医院进行LDCT肺癌筛查的2 056例受检者的资料。根据性别、国内肺癌高危人群年龄段,以及实际检出高危人群年龄段三种方法进行分组,比较各组间肺癌检出率的差异。

结果

2 056例受检者中,确诊肺癌22例,其中腺癌20例,鳞癌2例。45~75岁共检出肺癌21例,占总检出人数的95.5%(21/22)。男性组肺癌检出率为0.8%(10/1 217),女性组为1.4%(12/839),两组比较差异无统计学意义(χ2=1.738,P=0.187)。根据国内肺癌高危人群定义中的年龄段分组,高危组(50~75岁)肺癌检出率为1.3%(15/1 158),低危组(<50岁或>75岁)为0.8%(7/898),两组比较差异无统计学意义(χ2=1.271,P=0.26)。根据实际检出高危人群的年龄段分组,新高危组(45~75岁)肺癌检出率为1.4%(21/1 502),新低危组(<45岁或>75岁)为0.2%(1/554),新高危组检出率显著高于新低危组(χ2=5.668,P=0.017)。

结论

鲁西冀南地区人群在LDCT肺癌筛查中,不仅要关注男性,也要关注女性;且将肺癌筛查高危人群年龄调整为45~75岁更为合适。

Objective

To investigate the differences in lung cancer detection rates with low-dose spiral CT(LDCT) among people with different genders and ages in western Shandong and southern Hebei, and provide evidence for making better screening programs.

Methods

The clinical data of 2 056 cases undergoing lung cancer screening with LDCT in Liaocheng Second People’s Hospital in 2015 were retrospectively analyzed. Patients were divided into groups by gender, by age based on expert consensus of high-risk population of lung cancer and by age according to the actual findings of high-risk population of lung cancer, respectively, and the lung cancer detection rates were compared between groups, respectively.

Results

Twenty-two of these 2 056 cases were confirmed as lung cancer, among whom 20 were adenocarcinoma and the other 2 were squamous cell carcinoma. Twenty-one(95.5%) cases with lung cancer aged between 45 and 75 years. The lung cancer detection rates of males and females were 0.8%(10/1 217) and 1.4%(12/839), respectively, and there was no significant difference between them(χ2=1.738, P=0.187). Based on expert consensus of high-risk population of lung cancer, the lung cancer detection rates of high-risk group(50-75 years old) and low-risk group(<50 years or >75 years) were 1.3%(15/1 158) and 0.8%(7/898), respectively, and there was no significant difference between them(χ2=1.271, P=0.26). According to the actual findings of high-risk population of lung cancer, the lung cancer detection rates of new high-risk group(45-75 years old) and new low-risk group(<45 years or >75 years) were 1.4%(21/1 502) and 0.2%(1/554), respectively, and there were significant differences between them (χ2=5.668, P=0.017).

Conclusions

Attention should be paid to lung cancer screening with LDCT both in males and females in western Shandong and southern Hebei, and the age of high-risk population of lung cancer is well to be defined as 45-75 years.

表1 不同年龄段总人数与肺癌检出数(例)
表2 按性别分组肺癌检出率比较[例,%]
表3 按原高危人群年龄分组肺癌检出率比较
表4 按新高危人群年龄分组肺癌检出率比较
[1]
陈万青,郑荣寿,张思维等. 2012年中国恶性肿瘤发病和死亡分析[J].中国肿瘤,2016,25(1):1-8.
[2]
EttingerDS. Ten years of progress in non-small cell lungcancer[J]. J Natl Compr Canc Netw, 2012,10(3):292-295.
[3]
Gloeckler RiesLA,ReichmanME,LewisDR, et al. Cancersurvival and incidence from the Surveillance, Epidemiology,and End Results(SEER)program[J].Oncologist, 2003, 8(6):541-552.
[4]
HowladerN, NooneAM, KrapchoM, et al. SEER Cancer Statistics Review, 1975-2009(Vintage 2009 Populations)based on November 2011 SEER data submission[DB/OL].Bethesda(MD):National Cancer Institute,2012.
[5]
张国桢,郑向鹏,李铭.微小肺癌——影像诊断与应对策略[M].北京:人民军医出版社,2015.
[6]
周莹,刘士远等,李琼,等. 临床IA期周围型肺腺癌病理性脉管浸润与其薄层CT征象的相关性研究[J].中华放射学杂志,2015,49(4):259-263.
[7]
TravisWD,BrambillaE,NoguchiM,et al. Internationalassociation for the study of lung cancer/american thoracicsociety/european respiratory society international multidisciplinary classification of lung adenocarcinoma[J].J Thorac Oncol.201 1,6(2):244-285.
[8]
中华医学会放射学分会心胸学组. 低剂量螺旋CT肺癌筛查专家共识[J]. 中华放射学杂志,2015,49(5): 328-335.
[9]
HenschkeCI,McCauleyDI,YankelevitzDF, et al. Early Lung Cancer Action Project: overall design and findings frombaseline screening[J].Lancet, 1999, 354(9173):99-105.
[10]
HenschkeCI,BoffettaP,GorlovaO, et al. Assessment of lung-cancer mortality reduction from CT screening[J]. LungCancer, 2011,71(3): 328-332.
[11]
AbedeDR,AdamsAM,BergCD, et al. Reduced lung—cancer mortality with low dose computed tomographic screening[J].N Ensl J Med,2011,365(5):395-409.
[12]
van KlaverenRJ,OudkerkM,ProkopM, et a1. Management of lung nodules detected by volume CT scanning[J]. N Engl J Med, 2009, 361(23):2221-2229.
[13]
唐威,吴宁等,黄遥,等. 4690例无症状健康体检者低剂量CT早期肺癌筛查研究[J]. 中华肿瘤杂志,2014,36(7):549-554.
[14]
吴宁,赵世俊.积极规范地开展低剂量螺旋CT肺癌筛查[J]. 中华放射学杂志,2015,49(5): 321-322.
[15]
张春芳,曾强,王维民,等. 体检人群肺癌筛查低剂量螺旋CT检出率与成本分析[J]. 中华肿瘤防治杂志,2015,22(4): 247-251.
[1] 顾莉莉, 姜凡. 安徽省超声产前筛查切面图像质量现状调查情况及分析[J/OL]. 中华医学超声杂志(电子版), 2024, 21(07): 671-674.
[2] 明昊, 肖迎聪, 巨艳, 宋宏萍. 乳腺癌风险预测模型的研究现状[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 287-291.
[3] 钱警语, 郑明明. 《2024意大利妇产科学会非侵入性和侵入性产前诊断指南》解读[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 486-492.
[4] 袁延丽, 屈卓军, 崔会慧, 王菁, 高贝贝, 潘院. 原发性肺癌切除术后谵妄的危险因素及预后分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 701-706.
[5] 井发红, 李丽娜, 高婷, 高艳梅, 杨楠, 李卓, 慕玉东. 肺癌立体定向放疗血清SAP 和MMPs 表达及临床意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 707-713.
[6] 邢嘉翌, 龚佳晟, 祝佳佳, 陆群. 肺癌化疗患者继发肺部感染的病原菌耐药性及炎症因子变化分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 714-718.
[7] 杨慧, 郭丽娟, 冯晓丹, 李静, 黄成谋, 蔡兴锐, 覃英娇, 王远礼. 非小细胞肺癌铂类药物耐药mi RNA表达特征及预测分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 719-724.
[8] 张卫锋, 张天翼, 赵正维, 王海强, 尹逊亮. VE /VCO2 斜率对肺癌肺叶切除术后心血管并发症的预测意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 725-730.
[9] 赖淼, 景鑫, 李桂珍, 李怡. 非小细胞肺癌EGFR 突变亚型的临床病理和预后意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 731-737.
[10] 梁丽斯, 李洁, 贺帅, 来艳君, 刘铭, 张琳. MMP-9、MMP-2 及TLR4、HE4对非小细胞肺癌早期诊断意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 756-761.
[11] 杨轲, 丁增巴姆, 马静, 李盼盼, 陈婷. 全程无缝隙肺康复训练在单孔胸腔镜肺叶切除术中的临床应用[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 801-804.
[12] 张礼江, 沈玲佳, 施我大. 倾向性评分匹配分析奥希替尼对晚期NSCLC 预后的影响[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 820-822.
[13] 钱春蕊, 周燕, 张晶, 蔡笃财, 门慧, 王松海, 黎莉, 邢龙. 高分辨率CT 与多层螺旋CT 在肺结节及早期肺癌中的应用[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 827-830.
[14] 刘一鸣, 温佳新, 赵恺, 薛志强. ⅢA 期肺腺癌新辅助治疗后胸腔镜右肺中下叶切除术[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 311-313.
[15] 蔡剑桥, 蒋雷. 单孔胸腔镜与开胸双袖式肺叶切除治疗非小细胞肺癌对比[J/OL]. 中华胸部外科电子杂志, 2024, 11(04): 225-230.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?